Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Damaj, G.
Right arrow Articles by Hermine, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damaj, G.
Right arrow Articles by Hermine, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:623-629, 2003
© 2003 European Society for Medical Oncology


Original Paper

Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review

G. Damaj1,+, V. Verkarre1, A. Delmer2, P. Solal-Celigny3, I. Yakoub-Agha5, C. Cellier4, F. Maurschhauser5, R. Bouabdallah6, V. Leblond7, F. Lefrère1, D. Bouscary8, J. Audouin2, B. Coiffier9, B. Varet1, T. Molina2, N. Brousse1 and O. Hermine1

1 Hôpital Necker Enfants-Malades, Paris; 2 Hôpital de l’Hôtel-Dieu, Paris; 3 Centre Hospitalier du Mans, Le Mans; 4 Hôpital Georges Pompidou, Paris; 5 Hôpital C. Huriez, Lille; 6 Institut Paoli-Calmettes, Marseille; 7 Hôpital Pitié-Salpetrière, Paris; 8 Hôpital Cochin, Paris; 9 Hôpital Pierre Bénite, Lyon, France

Received 6 November 2002; revised 26 November 2002; accepted 13 January 2003

Background:

To describe better the clinical, biological, endoscopic and pathological presentations, as well as the outcome, of primary follicular lymphoma (FL) of the gastrointestinal (GI) tract.

Patients and methods:

From November 1983 to February 2001, 25 eligible patients with primary FL of the GI tract were retrieved from several French Departments of Pathology departments based on histological diagnosis and immunophenotype. Median age was 56 years (range 44–71) with a sex ratio female/male of 2 (17/8).

Results:

Abdominal pain was the main presenting symptom followed by intestinal obstruction. The small intestine was the most common site of involvement. Lesions were unifocal in the majority of patients (15/25). A pattern similar to lymphomatous polyposis was observed in 50% (7/14) of patients. Twelve patients had stage I, 10 patients stage II and three patients stage IV disease, and there was minimal extra intestinal involvement. Lymphoma tissues were composed of neoplastic follicles, most of which were grade 1 according to the World Health Organization (WHO) classification. The immunophenotype of the lymphoma cells was CD20+, CD10+, bcl2+ and CD5–. In tissue samples, IgH/bcl2 rearrangement at the MBR locus was present in 11 of 14 patients tested. Seven patients did not receive any treatment; four of them progressed after a median follow-up of 37.5 months. Treatment was otherwise heterogeneous, and complete remission was obtained in 15 patients which lasted for a median of 31 months. Relapses were either in the GI tract (n = 3) or outside the GI tract (n = 3). After a median follow-up of 34 months (range 5–203), 22 patients were still alive (complete remission, 11; partial remission, three; stable disease, six; progressive disease, two).

Conclusions:

Primary FL of the GI tract is a predominantly female lymphoma that most frequently involves the small intestine. Since the endoscopic and clinical presentation may not be different from lymphomatous polyposis, which is often associated with mantle cell origin of tumor cells, it is mandatory to perform an immunohistological and, if possible, a molecular analysis of GI lymphoma. The course of the disease is indolent and does not differ from nodal FL. Thus, therapy may not be required unless significant clinical symptoms are present or until disease progression.

Key words: follicular, intestinal, lymphoma, primary


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ASH Education BookHome page
G. A. Salles
Clinical Features, Prognosis and Treatment of Follicular Lymphoma
Hematology, January 1, 2007; 2007(1): 216 - 225.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.